// App-Quantinova.ai

3566 : Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 1928z CAR-Targeted T Cells

Researchers

Presenter

  • Marco L Davila

Principal Investigators

  • Isabelle Riviere

  • Xiuyan Wang

  • Jae H Park

  • Jolanta Stefanski

  • Clare Taylor

  • Qing He

  • Malgorzata Olszewska

  • Teresa Wasielewska

  • Oriana Borquez-Ojeda

  • Jinrong Qu

  • Shirley Bartido

  • Joseph G. Jurcic

  • Dan Douer

  • Mark G. Frattini

  • Michel Sadelain

  • Renier J Brentjens

Medical Centers

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • C-X-C motif chemokine ligand 8

  • Interleukin 6

  • Interleukin-2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01044069

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved